Examining the Challenging and Strategies for Improving Prostate Cancer Screening in Nigeria

Authors

  • Audu Jonah
  • Chock, J. J.
  • Sunday, A. M.

DOI:

https://doi.org/10.64321/jcr.v2i5.01

Keywords:

challenges, strategies, digital rectal examination, prostate cancer, prostate specific antigen, screening

Abstract

Background: Prostate cancer has been described as the leading cause of cancer-related deaths among men aged 40 years and above, especially in developing countries including Nigeria. By 2030, the global burden of prostate cancer which is currently the fifth leading cause of death worldwide is expected to hit 1.7 million new cases and 499,000 new deaths. Although the precise causes of prostate cancer are unknown, age, race, family history, lifestyle, and genetic variations are considered to be important risk factors. Digital rectal examination and prostate specific antigen screening are two methods of routinely screening for prostate cancer that can help discover the disease early and optimize incidence, minimize prevalence, and lower the death rate. According to studies, men from Nigeria are less likely to undergo screening because of a variety of issues, including fatalistic views, a lack of awareness of prostate cancer and its risk factors, false assumptions about the process, and a lack of support from the service provider. Objectives; The purpose of this review is to examine challenges and strategies to improve prostate cancer screening and offer suggestions for enhancing them in Nigeria. Method; The Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Review (PRISMA-ScR) standards were followed in the conduct of this review. Using search keywords like prostate cancer, risk factors, screening, and preventative approaches, scholarly papers published in electronic databases including PubMed, Scopus, and Google Scholar from 2018-2024 were obtained for this review Conclusion; This analysis suggests that institutional frameworks and policy guidelines be established and maintained in order to develop programs that educate Nigerian men about prostate cancer and the advantages of early screening.

Author Biographies

Audu Jonah

Department of Medical Laboratory Science, Faculty of Health Sciences, Bingham University, Karu, Nasarawa State, Nigeria

Chock, J. J.

Department of Medical Laboratory Science, Faculty of Health Sciences, Bingham University, Karu, Nasarawa State, Nigeria

Sunday, A. M.

Peak Medical Laboratories Limited, Off University of Abuja Teaching Hospital, Behind Union Bank Gwagwalada, Federal Capital Territory-Abuja. Nigeria

References

Neal D. Shore · Alicia K. Morgans · Ghassan El Haddad · Sandy Srinivas · Matthew Abramowitz. Addressing Challenges and Controversies in the Management of Prostate Cancer with Multidisciplinary Teams. Targeted Oncology (2022) 17:709–725 https://doi.org/10.1007/s11523-022-00925-7

Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7–33. https:// doi. org/ 10. 3322/ caac.21708.

Haffner MC, Zwart W, Roudier MP, True LD, Nelson WG, Epstein JI, et al. Genomic and phenotypic heterogeneity in prostate cancer. Nat Rev Urol. 2021;18:79–92. https:// doi. org/ 10. 1038/ s41585- 020- 00400-w.

Sung H, Ferlay J, Siegel RL,. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3): 209-249. doi:10.3322/caac.21660.

World Bank. Population - Total Nigeria.Washington, DC: Data - World Bank; Published 2020. https://data.worldbank.org/indicator/SP.POP.TOTL?locations=NG. Accessed February 5,2022.

Nigerian National Bureau of Statistics. Distribution of youth (15-35) by age group and sex. 2012 National Baseline Youth Survey. National Baseline Youth Survey Report_1.pdf. Published 2012. https://www.nigerianstat.gov.ng/pdfuploads/2102. Accessed February 5, 2022.

Atara Ntekim,MD, Ayorinde Folasire,MD, and Oluwaponmile A. Odukoya, The Prevalence of Prostate Cancer Among Young Men Below 55 Years of Age in Nigeria. Cancer Control 2023; 30: 1–7 sagepub.com/journals-permissions DOI: 10.1177/10732748231175255 journals.sagepub.com/home/ccx

The Global Cancer Observatory: Nigeria. International Agency for Research on Cancer, World Health Organization, 2021. https://gco.iarc.fr/today/data/ factsheets/populations/566-nigeria-fact-sheets.pdf

Bray F, Ferlay J, Soerjomataram I: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394-424, 2018

Omonisi AE, Liu B, Parkin DM: Population-based cancer registration in sub-Saharan Africa: Its role in research and cancer control. JCO Glob Oncol 6:1721-1728, 2020

https://training.seer.cancer.gov/prostate/anatomy/

https://www.cancer.org/cancer/types/prostate-cancer/detection-diagnosis-staging/staging.html#:~:text=The%20main%20stages%20of%20prostate,means%20cancer%20has%20spread%20more.

https://www.cdc.gov/prostate-cancer/risk-factors/index.html 2024

Mbah-Omeje K. N.;Iyke, C. A. And Amughe, S. C. Prostate cancer screening in Nigerian men: perceived barrier and recommendations. IJAAR Publishing 2022. https://www.ijaar.org/prostate-cancer-screening-in-nigerian-men-perceived-barriers-and-recommendations/

Paiva, E.P., Motta, M.C., and Griep, R.H. (2011). Barriers relatedto screening examinations for prostate cancer. Revista Latino Americana de Enfermagem, 19 (1): 73-80.

Smith, R.A., Manassaram-Baptiste, D., Brooks, D., Cokkinides, V.,Doroshenk, M., and Saslow, D. (2014). Cancer screening in theUnited States, 2014: A review of current American Cancer Societyguidelines and current issues in cancer screening”. CA CancerJournal for Clinicians, 64(1): 30-51.

Prostate Cancer Screening – NCI 2024 https://www.cancer.gov/types/prostate/patient/prostate-screening-pdq

18. Center for Disease Control and Prevention (2022). ProstateCancer: What is screening for prostate cancer. https://www.cdc.gov/cancer/prostate/basic_info/screening.htm#:~:text=A%20blood%20test%20called%20a,conditions%20that%20affect%20the%20prostate.

Prostate cancer early detection, diagnosis, and staging .American cancer 2024 cancer.org | 1.800.227.2345

Diagnosis and treatment - Mayo Clinic, 2024. https://www.mayoclinic.org/diseases-conditions/prostate-cancer/diagnosis-treatment/drc-20353093?p=1

Prostate Cancer Treatment (PDQ®)–Patient Version, 2024. https://www.cancer.gov/types/prostate/patient/prostate-treatment-pdq

Kolade, O.A. (2017). Knowledge and utilization of prostate cancerscreening services among male civil servants in Iseyin local government area, Oyo state, Nigeria. European Journal of Biologyand Medical Science Research, 5(3): 38:45.

Awosan, K. J., Yanusa, E. U., Agwu, N. P. and Taofiq, S. (2018).Knowledge of prostate cancer screening practices among men in Sokoto, Nigeria. Asian Journal of Medical Sciences, 9(6): 51-56.

Mutua, K., Pertet, A. M. and Otieno, C. (2017). Cultural factors associated with the intent to be screened for prostate cancer among adult men in a rural Kenyan community. BMC PublicHealth, 17(1): 894. https://doi.org/10.1186/s12889-017-4897-0.

Fidelis, C.B.,Germana, H. L., Kåre, M., and Elia, J. M. (2019).Knowledge, Perceived Risk and Utilization of Prostate CancerScreening Services among Men in Dar Es Salaam, Tanzania.International Journal of Cancer, 2019:1-6.vv

Downloads

Published

2025-09-02

How to Cite

Audu Jonah, Chock, J. J., & Sunday, A. M. (2025). Examining the Challenging and Strategies for Improving Prostate Cancer Screening in Nigeria . Journal of Current Research and Studies, 2(5), 1–16. https://doi.org/10.64321/jcr.v2i5.01